Related Experiment Video
Updated: Oct 28, 2025

09:54
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
3.7K
Radium-223 dichloride causes transient changes in natural killer cell population and cytotoxic function
Calvin N Leung1, Donna M Howell1,2, Roger W Howell1
1Department of Radiology, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
International Journal of Radiation Biology
|July 15, 2021
Summary
Radium-223 dichloride (²²³RaCl₂) impacts natural killer (NK) cell function in mice, showing enhanced activity at 12 days but diminished activity by 19 days post-administration. This suggests a therapeutic window for combining ²²³RaCl₂ with other cancer treatments.
Area of Science:
- Immunology
- Radiobiology
- Oncology
Background:
- Natural killer (NK) cells are crucial for innate and adaptive immunity.
- The effects of chronic high-linear energy transfer (LET) alpha particle exposure from radionuclides on NK cells are not well understood.
- Previous research focused on ionizing radiation's impact on NK cell cytotoxicity, but not specifically on alpha particle emitters like ²²³RaCl₂.
Purpose of the Study:
- To investigate the effects of ²²³RaCl₂ on the population size and function of splenic NK cells.
- To determine how chronic alpha particle exposure influences NK cell activity in vivo.
- To identify potential therapeutic windows for combining ²²³RaCl₂ with other immunotherapies.
Main Methods:
- Swiss Webster mice received intravenous injections of 0, 50, or 600 kBq/kg of ²²³RaCl₂.
- Spleens were collected at 5, 12, and 19 days post-injection for analysis.
- Flow cytometry assessed splenocyte subpopulations (B, T cells, NK cells), and NK cell function was measured using the ⁵¹Cr-release assay with YAC-1 target cells.
Main Results:
- The total splenocyte count remained unaffected by ²²³RaCl₂ administration.
- Significant alterations were observed in NK cell and CD8 T lymphocyte distribution.
- NK cell functional activity showed a substantial increase at 12 days post-administration but a marked decrease by day 19.
Conclusions:
- ²²³RaCl₂ modulates NK cell functional activity, with effects varying based on administered dose and time post-administration.
- The observed biphasic effect (enhancement followed by diminution) suggests a dynamic interplay between ²²³RaCl₂ and NK cell responses.
- These findings indicate a potential optimal time frame for utilizing ²²³RaCl₂-induced NK cell responses in conjunction with other cancer therapies.

